Industry News
Semaglutide: A Star Product In The Field …
In this article, we will introduce this new star semaglutide in the hypoglycemic and weight loss field.
Clinical Toxicity Of Antibody Drug Conjug…
Antibody-drug conjugates side effects should not be ignored.
Targeted Drug Therapy And Immunotherapy F…
Breast cancer is the most common cancer in the world. This article introduces targeted drug therapies and immunotherapies commonly used in the treatment of breast cancer.
Directions for Next Generation Antibody-D…
Three generations of ADCs overview and next generation ADC forecast.
5 ADC Targets And Representative Drugs Fo…
In this article, five potential ADC targets for NSCLC and representative drugs are briefly introduced.
Emerging Role of Dual GLP-1 Receptor Agon…
Today, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) are one of the most attractive option for the treatment diabetes.
Metformin, The Next "Miracle Drug&qu…
In this article, metformin is introduced from the development history, pharmacological properties, molecular mechanism of action and its clinical application.
Chemiluminescence Immunoassay (CLIA) Labe…
The common labels of chemiluminescent immunoassays is alkaline phosphatase (ALP).
Top 2 Targets of ADC: HER2 & Trop2
HER2 and Trop2 are the most widely used targets for ADC drugs.
Development And Application of "Clic…
On Oct 5th, the 2022 Nobel Prize in Chemistry was awarded to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless for their contributions to "the development of click chemistry and …